10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 255 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,046 | +142.1% | 18,731 | +141.9% | 0.47% | +218.2% |
| Q1 2023 | $432 | -55.1% | 7,743 | -70.7% | 0.15% | -57.5% |
| Q4 2022 | $962 | -99.6% | 26,410 | +241.1% | 0.35% | +329.6% |
| Q3 2022 | $221,000 | -36.9% | 7,743 | 0.0% | 0.08% | -40.0% |
| Q2 2022 | $350,000 | -40.6% | 7,743 | 0.0% | 0.14% | +2.3% |
| Q1 2022 | $589,000 | -48.9% | 7,743 | 0.0% | 0.13% | -11.4% |
| Q4 2021 | $1,153,000 | +2.3% | 7,743 | 0.0% | 0.15% | -21.2% |
| Q3 2021 | $1,127,000 | -74.2% | 7,743 | -65.2% | 0.19% | -86.1% |
| Q2 2021 | $4,360,000 | +15.0% | 22,264 | +6.3% | 1.36% | +10.4% |
| Q1 2021 | $3,792,000 | -64.5% | 20,951 | -72.3% | 1.24% | -69.0% |
| Q4 2020 | $10,695,000 | +131.3% | 75,531 | +103.7% | 3.99% | +78.3% |
| Q3 2020 | $4,624,000 | +980.4% | 37,087 | +673.1% | 2.24% | +876.4% |
| Q2 2020 | $428,000 | – | 4,797 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |